C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and the People’s Republic of China.
The last earnings update was 146 days ago.
Discounted Cash Flow Calculation for SEHK:3309 using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for
C-MER Eye Care Holdings
is arrived at by discounting future cash flows to their present value using the 2 stage method. We use
analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.
SEHK:3309 DCF 1st Stage: Next 5 year cash flow forecast
The current share price of
C-MER Eye Care Holdings
is above its future cash flow value.
Often investors are willing to pay a
for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
C-MER Eye Care Holdings's
is considered below, and whether this is a fair price.
Price based on past earnings
C-MER Eye Care Holdings's earnings available for a low price, and how does
this compare to other companies in the same industry?
C-MER Eye Care Holdings's earnings are expected to grow significantly at over 20% yearly.
C-MER Eye Care Holdings's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
C-MER Eye Care Holdings's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
C-MER Eye Care Holdings
has a total score of
1/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
C-MER Eye Care Holdings's finances.
The net worth of a company is the difference between its assets and liabilities.
C-MER Eye Care Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
C-MER Eye Care Holdings's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
C-MER Eye Care Holdings's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
Low level of unsold assets.
Debt is covered by short term assets, assets are 69.3x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
What Should You Know About C-MER Eye Care Holdings Limited's (HKG:3309) Capital Returns?
and want a simplistic look at the return on C-MER Eye Care Holdings Limited (HKG:3309) stock. … Your equity share is granted in return for the capital provided to the business to operate, and in order for an investment to be successful the business has to create earnings from the funds that make up this capital. … To understand C-MER Eye Care Holdings’s capital returns we will look at a useful metric called return on capital employed.
Why I Bought C-MER Eye Care Holdings Limited (HKG:3309)
C-MER Eye Care Holdings Limited (HKG:3309)'s outlook is one of buoyant sentiment as it continues to post exciting top-line revenue growth. … C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and the People’s Republic of China. … Founded in 2012, it currently operates in Hong Kong at a market cap of HK$8.25b.
C-MER Eye Care Holdings Limited (HKG:3309) Has Attractive Fundamentals, Here's Why
Building up an investment case requires looking at a stock holistically. … Today I've chosen to put the spotlight on C-MER Eye Care Holdings Limited (HKG:3309) due to its excellent fundamentals in more than one area.
Should You Expect C-MER Eye Care Holdings Limited (HKG:3309) To Continue Delivering An ROE Of 25.49%?
See our latest analysis for C-MER Eye Care Holdings What you must know about ROE Return on Equity (ROE) weighs C-MER Eye Care Holdings’s profit against the level of its shareholders’ equity. … For now, let’s just look at the cost of equity number for C-MER Eye Care Holdings, which is 4.96%. … Since C-MER Eye Care Holdings’s return covers its cost in excess of 20.53%, its use of equity capital is efficient and likely to be sustainable.
Stock Pick Of The Day: C-MER Eye Care Holdings Limited (HKG:3309)
There's no stopping the C-MER Eye Care Holdings Limited (SEHK:3309) growth train, with analysts forecasting high top-line growth in the near future. … Net income is expected to reach HK$103.00M over the next year, and over the next five years, earnings are predicted to grow at an annual rate of 49.76% on average, compared to the industry average growth of 17.52%. … 3309 has high near term liquidity, with short term assets (cash and other liquid assets) amply covering upcoming one-year liabilities, as well as long-term commitments.
Did C-MER Eye Care Holdings Limited's (HKG:3309) Recent Earnings Growth Beat The Trend?
When C-MER Eye Care Holdings Limited (SEHK:3309) announced its most recent earnings (30 June 2017), I compared it against two factor: its historical earnings track record, and the performance of its industry peers on average. … See our latest analysis for C-MER Eye Care Holdings Did 3309's recent earnings growth beat the long-term trend and the industry? … For C-MER Eye Care Holdings, its most recent earnings (trailing twelve month) is HK$51.67M, which, relative to the prior year's level, has risen by 21.29%.
Should You Sell C-MER Eye Care Holdings Limited (HKG:3309) At This PE Ratio?
Formula Price-Earnings Ratio = Price per share ÷ Earnings per share P/E Calculation for 3309 Price per share = HK$13.26 Earnings per share = HK$0.071 ∴ Price-Earnings Ratio = HK$13.26 ÷ HK$0.071 = 187.1x On its own, the P/E ratio doesn’t tell you much; however, it becomes extremely useful when you compare it with other similar companies. … We preferably want to compare the stock’s P/E ratio to the average of companies that have similar features to 3309, such as capital structure and profitability. … For example, if you are inadvertently comparing riskier firms with 3309, then 3309’s P/E would naturally be higher than its peers since investors would reward its lower risk with a higher price.
C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and the People’s Republic of China. The company operates eye and surgery centers, and satellite clinics that provide cataract and intraocular lens implant, refractive correction, corneal and external eye disease, glaucoma, vitreo-retinal disease, oculoplastic and orbital disease, and squint and pediatric ophthalmology services. It also sells vision aid and pharmaceutical products. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.